Unknown NA INTERVENTIONAL 2-arm NCT03462095

De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)

Non-intensive But Non-interruptive Treatment of Adult Ph-negative Acute Lymphoblastic Leukemia With Randomization for Maintenance or Autologous Hematopoietic Stem Cell Transplantation (HSCT) Followed by Maintenance in T-cell ALL Patients

Sponsor: National Research Center for Hematology, Russia

Conditions Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions Autologous HSCT

Updated 7 times since 2018 Last updated: Mar 12, 2018 Started: Jan 31, 2017 Primary completion: Dec 1, 2019 Completion: Dec 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03462095, this NA trial focuses on Precursor Cell Lymphoblastic Leukemia-Lymphoma and remains ongoing. Sponsored by National Research Center for Hematology, Russia, it has been updated 7 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Recruiting NA
Mar 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Research Center for Hematology, Russia

Data source: National Research Center for Hematology, Russia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Moscow, Russia